SoftBank-Backed Synthetic Biology Startup Raises $300 Million to Build a Better Microbe

Synthetic biology startup Zymergen Inc. has raised $300 million in a new funding round—a signal of investors’ confidence that biological science can be harnessed in novel ways to manufacture products.